Neuromyelitis optica (NMO), or Devic’s disease, is an inflammation of the sheath that protects the nerves in the eyes and the spinal cord. It can lead to weakness, eye pain, and temporary vision loss.

Neuromyelitis optica, or NMO, is a rare disease that mostly affects your eyes and spinal cord. It’s also known as Devic's disease. NMO happens when your body’s immune system attacks healthy cells in ...

Neuromyelitis optica is a rare chronic condition that causes eye pain and even vision loss. This disease happens when your own immune system attacks your nervous system. In this article, we look at ...

Multiple sclerosis (MS) is a disease in which the body’s immune system attacks myelin, the outside layer of nerve cells. Neuromyelitis optica (NMO) is also an immune system attack. However, in this ...

A monoclonal antibody (mAb) against a glycoprotein called repulsive guidance molecule-a (RGMa) may provide an efficient therapeutic strategy for treating neuromyelitis optica (NMO), scientists at ...

STOCKHOLM — A new drug for the treatment of neuromyelitis optica (NMO) — an aggressive inflammatory, immune-mediated disorder of the central nervous system often confused with a severe form of ...

In 1999, Wingerchuk et al. proposed the following diagnostic criteria for Devic's neuromyelitis optica (NMO): optic neuritis, acute myelitis, and no symptoms implicating CNS involvement beyond the ...

SAN DIEGO — Treatment with daratumumab, a monoclonal antibody approved to treat multiple myeloma, was associated with a significant decrease in relapse risk in patients with aquaporin-4 immunoglobulin ...

WASHINGTON -- Patients with IgG4-related disease appeared to benefit from inebilizumab (Uplizna), currently approved for neuromyelitis optica (NMO), in a pivotal clinical trial. Just 10% of patients ...

Neuromyelitis optica (NMO) can affect your vision, your muscles, and your emotions. It sometimes leads to lasting symptoms or disabilities. But certain devices, lifestyle changes, and therapies can ...